AbbVie (ABBV) shares rise on earnings beat - prepared for loss of Humira exclusivity
Tweet Send to a Friend
AbbVie (NYSE: ABBV) shares are up more than 3% in early Thursday trading after the company topped earnings estimates for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
